S-Adenosylmethionine Inhibits the Proliferation of Retinoblastoma Cell Y79, Induces Apoptosis and Cell Cycle Arrest of Y79 Cells by Inhibiting the Wnt2/β-Catenin Pathway
By:
References
- Bai QL, Hu CW, Wang XR et al (2017) Mir-616 promotes proliferation and inhibits apoptosis in glioma cells by suppressing expression of Sox7 via the Wnt signaling pathway. Eur Rev Med Pharmacol Sci 21:5630–5637. https://doi.org/10.26355/eurrev_201712_14006
- Dimaras H, Corson TW, Cobrinik D et al (2015) Retinoblastoma. Nat Rev Dis Primers 1:15021. https://doi.org/10.1038/nrdp.2015.21
- Galizia I, Oldani L, Macritchie K et al (2016) S-adenosyl methionine (same) for depression in adults. Cochrane Database Syst Rev 10:CD011286. https://doi.org/10.1002/14651858.CD011286.pub2
- Hayashi T, Teruya T, Chaleckis R et al (2018) S-adenosylmethionine synthetase is required for cell growth, maintenance of go phase, and termination of quiescence in fission yeast. iScience 5:38–51. https://doi.org/10.1016/j.isci.2018.06.011
- He L, Zhou H, Zeng Z et al (2019) Wnt/Β-catenin signaling cascade: A promising target for glioma therapy. J Cell Physiol 3:2217–2228. https://doi.org/10.1002/jcp.27186
- Kruglova MP, Ivanov AV, Virus ED et al (2021) Urine S-adenosylmethionine are related to degree of renal insufficiency in patients with chronic kidney disease. Lab Med 52:47–56. https://doi.org/10.1093/labmed/lmaa034
- Liu Y, Bi T, Yuan F et al (2020) S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of Jak2/Stat3 pathways. Naunyn Schmiedebergs Arch Pharmacol 393:2507–2515. https://doi.org/10.1007/s00210-020-01858-6
- Lu Y, Yang Y, Kang Z et al (2020) High-dose S-adenosylmethionine combined with ursodeoxycholic acid is more suitable for the treatment of cholestatic liver disease. Int J Clin Exp Med 13:7365–7371.
- Luo Y, Zhou C, He F et al (2022) Contemporary update of retinoblastoma in China: Three-decade changes in epidemiology, clinical features, treatments, and outcomes. Am J Ophthalmol 236: 193–203. https://doi.org/10.1016/j.ajo.2021.09.026
- Mahmood N, Arakelian A, Cheishvili D et al (2020) S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis. J Cell Mol Med 24:10322–10337. https://doi.org/10.1111/jcmm.15642
- Parashar S, Cheishvili D, Arakelian A et al (2015) S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: Therapeutic and diagnostic clinical applications. Cancer Med 4:732–744. https://doi.org/10.1002/cam4.386
- Pascual-Pasto G, Bazan-Peregrino M, Olaciregui NG et al. (2019) Therapeutic targeting of the Rb1 Pathway in retinoblastoma with the oncolytic adenovirus Vcn-01. Sci Transl Med 11:eaat9321. https://doi.org/10.1126/scitranslmed.aat9321
- Perugorria MJ, Olaizola P, Labiano I et al (2019) Wnt-beta-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol 16:121–136. https://doi.org/10.1038/s41575-018-0075-9
- Singh V, Walter V, Elcheva I et al (2023) Global role of Igf2bp1 in controlling the expression of Wnt/Β-Catenin-regulated genes in colorectal cancer cells. Front Cell Dev Biol 11:1236356. https://doi.org/10.3389/fcell.2023.1236356
- Spitzner M, Emons G, Schütz KB et al (2021) Inhibition of Wnt/β-catenin signaling sensitizes esophageal cancer cells to chemoradiotherapy. Int J Mol Sci 22:10301. https://doi.org/10.3390/ijms221910301
- Vincenzi B, Russo A, Terenzio A et al (2018) The use of same in chemotherapy-induced liver injury. Crit Rev Oncol Hematol 130:70–77. https://doi.org/10.1016/j.critrevonc.2018.06.019
- Yan H, Li M, Zhang Z et al (2021) [Analysis of fundus examination results in 8 808 pediatric patients in Northwest China]. Zhonghua Yan Ke Za Zhi 10:777–783. https://doi.org/10.3760/cma.j.cn112142-20201217-00823
- Zsigrai S, Kalmár A, Nagy ZB et al (2020) S-adenosylmethionine treatment of colorectal cancer cell lines alters DNA methylation, DNA repair and tumor progression-related gene expression. Cells 9:1864. https://doi.org/10.3390/cells9081864
DOI: https://doi.org/10.2478/aite-2024-0020 | Journal eISSN: 1661-4917
Language: English
Submitted on: Apr 24, 2024
Accepted on: Aug 5, 2024
Published on: Oct 4, 2024
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2024 Mushi Liu, Youchaou Mobet, Hong Shen, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.